Skip to main content

Shares of over-the-counter drugmaker



jumped Friday after the company announced a $410 million acquisition of five consumer product brands from

Johnson & Johnson

(JNJ) - Get Johnson & Johnson (JNJ) Report



(PFE) - Get Pfizer Inc. Report

. The company will buy ACT mouthwash, Unisom over-the-couter sleep aids, Cortizone anti-itch products, diarrhea treatment Kaopectate, and diaper rash ointment Balmex. Chattem's shares gained 20.1% to $41.35.

Shares of cancer drug developer



were up 12.5% to 90 cents after the company said regulators agreed to a trial designed to study a group treated with the drug Genasense compared with a group that will not receive the drug. Both groups will be given the chemotherapy drug fludarabine plus



TheStreet Recommends


Memory Pharmaceuticals


shares also rose on an announcement of a private placement. In a press release at the close of trading Thursday, Memory said it entered an agreement with Great Point Partners and MPM Capital for a placement of approximately 28.2 million shares at $1.11 a share. The company will also issue warrants for the purchase of approximately 7.1 million more shares at $1.33 a share to these investors. The deal is expected to raise $32.2 million. Shares were up 11.8% to $1.33.




said the European Union approved its Suboxone tablets for the treatment of opioid dependency in individuals aged 15 and older. Shares settled a penny lower midday to $22.09 after jumping higher in early trading.

Among other health stocks falling Friday were


(SNY) - Get Sanofi Sponsored ADR Report

, down 2.6% to $43.45;


(AZN) - Get Astrazeneca PLC Sponsored ADR Report

, falling 1.8% to $61.88;


(AMGN) - Get Amgen Inc. Report

off 1.4% to $73.72;

Novo Nordisk

(NVO) - Get Novo Nordisk A/S Sponsored ADR Class B Report

3.2% lower to $71.81; and



, whose shares dipped 0.8% to $10.40.

Those moving higher included

La Jolla Pharmaceutical

(LJPC) - Get La Jolla Pharmaceutical Company Report

, up 1.7% to $3.60;

Osiris Therapeutics

(OSIR) - Get Osiris Therapeutics, Inc. Report

gaining 6.7% to $11.37;

Ligand Pharmaceuticals

(LGND) - Get Ligand Pharmaceuticals Incorporated Report

up 1.8% to $10.12; and


(GSK) - Get GlaxoSmithKline plc Sponsored ADR Report

, up 0.5% to $54.18 following a significant jump earlier Friday morning.